A61K 9/0034
Urogenital system
Official title: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
A61K9/0034 (Urogenital system) appears on 1,956 US grants and 2,963 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,956
- Published applications
- 2,963
- Assignees
- 1,285
- Inventors
- 4,255
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 14 | 0 |
| 1978 | 10 | 0 |
| 1979 | 11 | 0 |
| 1980 | 16 | 0 |
| 1981 | 20 | 0 |
| 1982 | 15 | 0 |
| 1983 | 13 | 0 |
| 1984 | 15 | 0 |
| 1985 | 9 | 0 |
| 1986 | 21 | 0 |
| 1987 | 8 | 0 |
| 1988 | 11 | 0 |
| 1989 | 11 | 0 |
| 1990 | 7 | 0 |
| 1991 | 12 | 0 |
| 1992 | 7 | 0 |
| 1993 | 20 | 0 |
| 1994 | 14 | 0 |
| 1995 | 13 | 0 |
| 1996 | 18 | 0 |
| 1997 | 22 | 0 |
| 1998 | 26 | 0 |
| 1999 | 39 | 0 |
| 2000 | 46 | 0 |
| 2001 | 35 | 18 |
| 2002 | 42 | 53 |
| 2003 | 40 | 84 |
| 2004 | 31 | 69 |
| 2005 | 19 | 84 |
| 2006 | 25 | 88 |
| 2007 | 14 | 87 |
| 2008 | 21 | 83 |
| 2009 | 10 | 90 |
| 2010 | 37 | 77 |
| 2011 | 31 | 90 |
| 2012 | 36 | 78 |
| 2013 | 48 | 103 |
| 2014 | 82 | 133 |
| 2015 | 101 | 163 |
| 2016 | 88 | 148 |
| 2017 | 92 | 159 |
| 2018 | 89 | 155 |
| 2019 | 101 | 171 |
| 2020 | 106 | 228 |
| 2021 | 102 | 182 |
| 2022 | 102 | 143 |
| 2023 | 82 | 154 |
| 2024 | 78 | 132 |
| 2025 | 86 | 106 |
| 2026 | 46 | 85 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- Controlled-release progesterone compositions and uses thereof8 Sep 2026US 12,728,133 B2Ceva Sante Animale
- Vaginal hydrogel8 Sep 2026US 12,728,166 B2
- Pharmaceutical composition for use in the treatment of cystitis of various etiologies1 Sep 2026US 12,721,862 B2Fidia Farmaceutici S. P. A.
- Vaginal measurements using a vaginal ring25 Aug 2026US 12,714,333 B2LiGalli B.V.
- Compositions and methods for treating vulvar and vaginal atrophy (vva)1 Oct 2026US 2026/0294846 A1
- Topical composition for the treatment of mucosal lesions with short gelling time1 Oct 2026US 2026/0294959 A1Inmedical Therapeutics, S.L.
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Levonorgestrel and compositions comprising the same17 Sep 2026US 2026/0272825 A1
- Cells expressing parathyroid hormone 1 receptor and uses thereof17 Sep 2026US 2026/0275277 A1Tithon Biotech Inc.
Most cited
By later US patents
- Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels548US 6,605,294 B2Incept, LLC · 2003
- Novel drug delivery device408US 3,993,073 AAlza Corporation · 1976
- Therapeutic device for osmotically dosing at controlled rate374US 4,160,020 AAlza Corporation · 1979
- Osmotic system for the controlled and delivery of agent over time343US 4,111,202 AAlza Corporation · 1978
- Device consisting of copolymer having acetoxy groups for delivering drugs343US 4,144,317 AAlza Corporation · 1979